Cyclica: Funding, Investors & Team (Oct 2026)
The preferred partner for data-driven drug discovery is Cyclica. We develop molecules that take into account the complexity of the illness. Our computational method for studying polypharmacology is exceptional in the field. We simultaneously assess numerous novel and uncommon on- and off-target interactions through a proteome-wide perspective. Additionally, we are the first business of our sort to include research to develop molecules later on. Our work is held accountable to biology, chemistry, physics, and genetics using a structure-based perspective. Please visit www.cyclicarx.com to learn more about Cyclica and how we collaborate.
Cyclica has raised $24.8M across 2 funding rounds on record, the most recent an undisclosed round of $1.8M announced in Nov 2022.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Cyclica Company Profile and Key Stats
Latest funding round on record: Nov 2022.
Cyclica Funding Rounds
Cyclica raised $23.0M in an undisclosed round announced in Jun 2020.
2.4 years later, an undisclosed round of $1.8M was announced in Nov 2022.
Cyclica Founders and Leadership Team
Contact details for the Cyclica team: 1 of 1 has an email address on file.
Start 14-day free trial →Cyclica Funding Compared to Other Biotechnology Startups
Cyclica's latest round of $1.8M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Cyclica in Biotechnology and Toronto
Companies Similar to Cyclica
Tydra Labs is a biotechnology company that transforms crustacean shell waste into chitin and bio-products.
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
Cyclica Funding FAQs
What does Cyclica do?
The preferred partner for data-driven drug discovery is Cyclica. We develop molecules that take into account the complexity of the illness. Our computational method for studying polypharmacology is exceptional in the field. We simultaneously assess numerous novel and uncommon on- and off-target interactions through a proteome-wide perspective. Additionally, we are the first business of our sort to include research to develop molecules later on. Our work is held accountable to biology, chemistry, physics, and genetics using a structure-based perspective. Please visit www.cyclicarx.com to learn more about Cyclica and how we collaborate.
How much funding has Cyclica raised?
Cyclica has raised $24.8M across 2 rounds on record. The most recent is an undisclosed round of $1.8M announced in Nov 2022.
When did Cyclica last raise funding?
Cyclica's most recent funding round on record is an undisclosed round of $1.8M, announced in Nov 2022.
Who is the CEO of Cyclica?
Naheed Kurji is listed as CEO at Cyclica.
Where is Cyclica headquartered?
Cyclica is based in Toronto, Ontario, Canada.
How many employees does Cyclica have?
Cyclica is in the 51-100 employee band.
How does Cyclica's funding compare to other Biotechnology startups?
Cyclica's latest round of $1.8M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Cyclica Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Cyclica is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.